Newron Pharmaceuticals SpA's market cap is currently $209.19M. The company's EPS TTM is CHF0; its P/E ratio is 8.75; Newron Pharmaceuticals SpA is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is CHF-1.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in EUR
Newron Pharmaceuticals SpA Earnings and Revenue History
